EPiC, a free dashboard built for GPs interested in improving their practice with respect to equitable prescribing of funded medicines, is now available
To sign up to EPiC, simply click here to begin the two-step sign up process.
EPiC, a free dashboard built for GPs interested in improving their practice with respect to equitable prescribing of funded medicines, is now available
To sign up to EPiC, simply click here to begin the two-step sign up process.
Late last year, PHARMAC announced the SGLT2 inhibitor empagliflozin (Jardiance®) and empagliflozin with metformin (Jardiamet®) will be funded for the treatment of type 2 diabetes under Special Authority.
Find out all you need to know about the Special Authority criteria.
If you are a GP practising in New Zealand and would like to use a data analytics tool that can help you assess your prescribing with respect to type-2 diabetes, and allow you to compare your prescribing behaviour to your peers, then sign up now. To sign up to EPiC, simply click here to begin the two-step sign up process.
We are excited to bring you this new programme aimed at improving medicine access equity for the people of Aotearoa New Zealand; giving clinicians the opportunity to reflect on practice and purpose
The highs and lows of launching a service during COVID
Take a tour around He Ako Hiringa’s new clinical education website